Advertisement

ADVERTISEMENT

Maria Asimopoulos

Conference Coverage
Immunotherapy Cost Savings Greater With Atezolizumab vs Pembrolizumab for NSCLC
03/21/2023
Maria Asimopoulos
Investigators compared the budget impact associated with maintaining atezolizumab as a preferred treatment option vs increasing the market share of pembrolizumab.
Investigators compared the budget impact associated with maintaining atezolizumab as a preferred treatment option vs increasing the market share of pembrolizumab.
Investigators compared the...
03/21/2023
First Report Managed Care
Conference Coverage
Study Identifies Global Drivers of COVID-19 Vaccine Hesitancy
03/21/2023
Maria Asimopoulos
Beyond efficacy, safety, and administration concerns, patient-level factors also played a role in vaccine hesitancy, according to research presented at AMCP 2023.
Beyond efficacy, safety, and administration concerns, patient-level factors also played a role in vaccine hesitancy, according to research presented at AMCP 2023.
Beyond efficacy, safety, and...
03/21/2023
First Report Managed Care
Conference Coverage
Annual Breast Cancer Prescription Expenditures Lower for Racial and Ethnic Minority Patients
03/20/2023
Maria Asimopoulos
To shed light on potential disparities in breast cancer care, investigators compared the prescription expenditures of African American, Hispanic, and White patients.
To shed light on potential disparities in breast cancer care, investigators compared the prescription expenditures of African American, Hispanic, and White patients.
To shed light on potential...
03/20/2023
Pharmacy Learning Network
Conference Coverage
Patient Characteristics Linked to Disparities in Mail-Order Pharmacy Utilization
03/20/2023
Maria Asimopoulos
Researchers examined the characteristics associated with the use of mail-order pharmacy and found significant disparities in utilization based on race, ethnicity, and other patient characteristics.
Researchers examined the characteristics associated with the use of mail-order pharmacy and found significant disparities in utilization based on race, ethnicity, and other patient characteristics.
Researchers examined the...
03/20/2023
Pharmacy Learning Network
News
OUD Treatment Inequities Identified for Medicaid Beneficiaries With Disabilities
03/16/2023
Maria Asimopoulos
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use...
03/16/2023
First Report Managed Care
News
Game-based Digital Therapeutic Improves ADHD Symptoms in Children, Adolescents
03/10/2023
Maria Asimopoulos
A game-based digital therapeutic reduced inattention and hyperactivity/impulsivity but was not more effective than medication, findings suggest.
A game-based digital therapeutic reduced inattention and hyperactivity/impulsivity but was not more effective than medication, findings suggest.
A game-based digital therapeutic...
03/10/2023
First Report Managed Care
News
FDA Approves Factor VIII Replacement Therapy for Hemophilia A
03/09/2023
Maria Asimopoulos
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, known by the branded name Altuviiio, is expected to hit the US market in April 2023.
Antihemophilic factor...
03/09/2023
First Report Managed Care
News
Study Shows Rapid Increase in Cannabis, Stimulant Use Disorder Diagnoses Among Veterans
03/09/2023
Maria Asimopoulos
Researchers studied substance use disorder diagnoses in VA patients from fiscal years 2010 to 2019, identifying trends by type and number of diagnoses.
Researchers studied substance use disorder diagnoses in VA patients from fiscal years 2010 to 2019, identifying trends by type and number of diagnoses.
Researchers studied substance...
03/09/2023
Veterans Health Today
News
Reviewing Atypical Antipsychotics for Patients With Parkinson Disease Psychosis
03/08/2023
Maria Asimopoulos
Researchers studied the efficacy and acceptability of using pimavanserin, quetiapine, olanzapine, clozapine, ziprasidone, and risperidone for patients with Parkinson disease psychosis.
Researchers studied the efficacy and acceptability of using pimavanserin, quetiapine, olanzapine, clozapine, ziprasidone, and risperidone for patients with Parkinson disease psychosis.
Researchers studied the efficacy...
03/08/2023
Annals of Long-Term Care
News
Real-World Evidence Reveals Patient Outcomes With Ibrutinib Treatment for CLL
03/03/2023
Maria Asimopoulos
In light of real-world data, researchers studied outcomes and prognoses in patients with chronic lymphocytic leukemia who received ibrutinib monotherapy.
In light of real-world data, researchers studied outcomes and prognoses in patients with chronic lymphocytic leukemia who received ibrutinib monotherapy.
In light of real-world data,...
03/03/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use